Publisher's Synopsis
This work integrates the environmental triggers of multiple sclerosis (MS) with genetic susceptibility to the disease, and presents developments in MS investigation. It highlights epidemiology, aetiology, pathogenesis, pathology, clinical features, and therapy. The book explains the most efficacious treatment strategies, including beta interferons, copolymer 1, cladribine, imuran, methotrexate, corticosteroids, and IV gamma globulin as well as symptomatic therapies such as symmetrel, cylert, tegretol, dilantin, lioresol, antidepressants and ditropan
